Or maybe Gerald is floating the possibility of spinning off the Diagnostic Division to the private equity people at Cavendish? (With current shareholders maintaining control, of course) Maybe he is dangling the historic and explosive potential of LymPro's launch in front of them? Maybe if Gerald gets enough interest from private equity, it will sway him one direction or another.
Gerald has several "financial engineering" ideas and depending on how much money he has to work with, he takes us down any one of several paths. This is like a chess match. Gerald has several pieces with several great moves he can make.
By September, maybe we're struggling to get to .20 cents, or maybe we're at .60 cents! I don't think Gerald knows. We're all waiting to see how this plays out.
News 
Market Data 
Discover 
